双侧视网膜母细胞瘤的基因组与转录组肿瘤异质性
该病例研究对2例双侧视网膜母细胞瘤患者行双侧眼球摘除后的肿瘤样本进行全外显子测序、拷贝数分析和基因表达分析,发现双眼肿瘤存在不同的基因组和基因表达特征,证实眼间异质性;1例眶复发与同侧眼肿瘤拷贝数改变相似,支持复发起源于同侧眼。
要点
- 双侧视网膜母细胞瘤双眼肿瘤间存在基因组和基因表达差异。
- 眶复发与同侧眼肿瘤拷贝数改变相似,支持同侧眼起源。
- 11q缺失可能与眼外复发相关。
核心结论
- 2例双侧视网膜母细胞瘤患者双眼肿瘤间观察到不同的基因组和基因表达特征,证实眼间异质性。
- 1例患者眶复发与同侧眼肿瘤拷贝数改变相似,支持复发起源于同侧眼。
- 11q缺失可能与眼外复发相关。
研究设计与样本
- 病例研究,纳入2例双侧视网膜母细胞瘤患者,均行 upfront 双侧眼球摘除。
- 肿瘤样本进行全外显子测序(Illumina平台)、DNA芯片(CytoScan或OncoScan)和基因表达芯片(Agilent)分析。
- 1例患者双侧肿瘤建立原代细胞培养用于基因表达研究。
主要发现
- 患者1双眼肿瘤均见1q和6p获得,左眼肿瘤及眶复发额外见2p获得(包含MYCN)。
- 患者1眶复发与左眼肿瘤拷贝数改变相似,眶复发额外检测到11q缺失。
- 患者2双眼肿瘤见共同拷贝数获得和缺失,左眼肿瘤进一步演化出2p获得(包含MYCN)。
- 患者2左眼与右眼肿瘤间MYCN和FOXG1基因通路表达存在差异。
临床怎么用
- 双侧视网膜母细胞瘤患者双眼肿瘤可能存在基因组异质性,考虑靶向治疗时需注意。
- 眶复发与同侧眼肿瘤拷贝数改变相似,提示复发可能起源于同侧眼。
局限性
- 仅2例病例,样本量小。
- 部分样本为石蜡包埋组织或细胞系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Comprehensive understanding of the genomic and gene-expression differences between retinoblastoma tumors from patients with bilateral disease may help to characterize risk and optimize treatment according to individual tumor characteristics. OBJECTIVE: To compare the genomic features between each eye and a specimen from an orbital relapse in patients with bilateral retinoblastoma. DESIGN, SETTING, AND PARTICIPANTS: In this case, 2 patients with retinoblastoma underwent upfront bilateral enucleation. Tumor samples were subjected to genomic and gene-expression analysis. Primary cell cultures were established from both of the tumors of 1 patient and were used for gene-expression studies. MAIN OUTCOMES AND MEASURES: Whole-exome sequencing was performed on an Illumina platform for fresh tumor samples and DNA arrays (CytoScan or OncoScan) were used for paraffin-embedded samples and cell lines. Gene-expression analysis was performed using Agilent microarrays. Germinal and somatic alterations, copy number alterations, and differential gene expression were assessed. RESULTS: After initial bilateral enucleation, patient 1 showed massive choroidal and laminar optic nerve infiltration, while patient 2 showed choroidal and laminar optic nerve invasion. Patient 1 developed left-eye orbital recurrence and bone marrow metastasis less than 1 year after enucleation. Both ocular tumors showed gains on 1q and 6p but presented other distinct genomic alterations, including an additional gain in 2p harboring the N-myc proto-oncogene (MYCN) in the left tumor and orbital recurrence. Similar copy number alterations between the orbital recurrence and the left eye supported the origin of the relapse, with an additional 11q loss only detected in the orbital relapse. Specimens from patient 2 showed common copy number gains and losses, but further evolution rendered a 2p gain spanning MYCN in the left tumor. For this patient, microarray expression analysis showed differential expression of the MYCN and the forkhead box protein G1 (FOXG1) gene pathways between the left and right tumors. CONCLUSIONS AND RELEVANCE: Differential genomic and gene expression features were observed between tumors in 2 patients with bilateral disease, confirming intereye heterogeneity that might be considered if targeted therapies are used in such patients. Chromosomal alteration profile supported the origin of the orbital recurrence from the homolateral eye in 1 patient. Loss in chromosome 11q may have been associated with extraocular relapse in this patient.
引用
- Winter U, Ganiewich D, Ottaviani D, et al. Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma. JAMA Ophthalmol. 2020. PMID: 32191268. doi:10.1001/jamaophthalmol.2020.0427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。